Home › NDC Lookup › RxCUI directory › RxCUI 805661

Armodafinil 250 MG Oral Tablet [Nuvigil] — RxCUI 805661

RxNorm drug concept · Semantic branded drug
RxCUI 805661 Semantic branded drug · SBD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI805661
Official nameArmodafinil 250 MG Oral Tablet [Nuvigil]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNuvigil 250 MG Oral Tablet
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)501 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Armodafinil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It promotes wakefulness, so yes, it has some similarities to stimulants like amphetamine in terms of keeping you alert. But its mechanism is different — it mainly works through the...
  • What exactly does armodafinil do — is it like a stimulant?
  • For sleep apnea or narcolepsy, take it once in the morning. For shift work disorder, take it about an hour before your shift starts. Food won't significantly change how much of the...
  • When should I take it, and does it matter if I eat first?
📖 Read our full Armodafinil guide →

🕸️ Concept Web — How Armodafinil 250 MG Oral Tablet [Nuvigil] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Armodafinil 250 MG Oral Tablet [Nuvigil] RxCUI 805661

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Armodafinil 641465
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nuvigil 710995
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Armodafinil Oral Tablet 724858
    • Armodafinil Oral Product 1158263
    • Armodafinil Pill 1158264
    • Armodafinil Oral Tablet [Nuvigil] 805658
    • Nuvigil Oral Product 1179387
    • Nuvigil Pill 1179388
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Armodafinil 250 MG Oral Tablet SCD · 724861
  • Armodafinil 250 MG SCDC · 724860
  • Armodafinil Oral Tablet SCDF · 724858
  • Armodafinil Oral Product SCDG · 1158263
  • Armodafinil Pill SCDG · 1158264

Brand-Name Concepts

  • Armodafinil 250 MG [Nuvigil] SBDC · 805660
  • Armodafinil Oral Tablet [Nuvigil] SBDF · 805658
  • Nuvigil Oral Product SBDG · 1179387
  • Nuvigil Pill SBDG · 1179388
  • Nuvigil BN · 710995

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 805661 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
60429-0001-30 30 TABLET in 1 BOTTLE (60429-001-30) Nuvigil Golden State Medical Supply, Inc. 2025-07-30
60429-0002-30 30 TABLET in 1 BOTTLE (60429-002-30) Nuvigil Golden State Medical Supply, Inc. 2025-07-30
60429-0003-30 30 TABLET in 1 BOTTLE (60429-003-30) Nuvigil Golden State Medical Supply, Inc. 2025-07-30
60429-0004-30 30 TABLET in 1 BOTTLE (60429-004-30) Nuvigil Golden State Medical Supply, Inc. 2025-07-30
60505-4846-03 30 TABLET in 1 BOTTLE (60505-4846-3) Nuvigil Apotex Corp. 2025-08-31
60505-4847-03 30 TABLET in 1 BOTTLE (60505-4847-3) Nuvigil Apotex Corp. 2025-08-31
60505-4849-03 30 TABLET in 1 BOTTLE (60505-4849-3) Nuvigil Apotex Corp. 2025-08-31
60505-4850-03 30 TABLET in 1 BOTTLE (60505-4850-3) Nuvigil Apotex Corp. 2025-08-31
63459-0215-30 30 TABLET in 1 BOTTLE (63459-215-30) Nuvigil Cephalon, LLC 2011-01-03
Observed labelers: Apotex Corp. (4) · Golden State Medical Supply, Inc. (4) · Cephalon, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.